Gaudium IVF & Women Health IPO

Gaudium IVF & Women Health IPO is listed on BSE and NSE, priced at ₹75–₹79 per share. The stock debuted at ₹83, delivering a listing gain of 5.1%. The IPO had a lot size of ₹189 shares and a minimum investment of ₹14,931.

Gaudium IVF & Women Health Limited IPO

Mainboard Listed
₹14,931 (189 Shares)
Minimum Investment
Check Allotment
IPO Dates
Feb 20, 2026 – Feb 24, 2026
Price band
₹75-79 per equity share
Minimum Investment
₹14,931
Issue size
₹165 Cr
Lot size
189
Allotment Date
Feb 25, 2026
Listing
Feb 27, 2026
Listing At
BSE, NSE

IPO timeline

  1. Feb 20, 2026

    Open Date

    Completed

  2. Feb 24, 2026

    Close Date

    Completed

  3. Feb 25, 2026

    Allotment Date

    Completed

  4. Feb 27, 2026

    Listing Date

    Completed

Price Summary

Last closing
116.79 (47.84%)
52 week high
133.00
52 week low
69.18
Last update

Gaudium IVF & Women Health IPO Subscription Details

View Subscription Details
QIB 1.62x
Retail 7.60x
NIIs 14.05x
bHNI 12.71x
sHNI 16.73x
Retail 7.60x
Total 7.27x

Gaudium IVF & Women Health IPO subscription status shows demand across QIB, NII, and retail categories, helping investors understand participation levels.

Last updated:

Gaudium IVF & Women Health IPO Essentials

Gaudium IVF & Women Health IPO Details

Gaudium IVF & Women Health IPO is priced at ₹75-79 per share with a total issue size of 165 crore. The IPO has a lot size of 189 shares and is listed on BSE and NSE.

Issue price
₹75-79 per equity share
Lot size
189 shares
Face value
₹5 Per Equity Share
Issue size
₹165 Crores : 90 Crores Fresh + 75 Crores OFS
Total issue size
2,08,86,200 shares
(aggregating up to ₹165 crore)
Fresh issue
1,13,92,500 shares
(aggregating up to ₹90 crore)
Offer for sale (OFS)
94,93,700 shares
(aggregating up to ₹75 crore)
Listing at
BSE, NSE
List price
83.0(NSE)
Listing date
Registrar
Bigshare Services Pvt.Ltd.
Lead manager
Sarthi Capital Advisors Pvt.Ltd.

Market Lot Size

Investors can bid for a minimum of 189 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.

Application Lots Shares Amount
Retail (min) 1 189 ₹14,931
Retail(max) 13 2,457 ₹1,94,103
sHNI(min) 14 2,646 ₹2,09,034
sHNI(max) 66 12,474 ₹9,85,446
sHNI(min) 67 12,663 ₹10,00,377

Gaudium IVF & Women Health IPO Documents

Gaudium IVF & Women Health IPO Reservation

Gaudium IVF & Women Health IPO reservation details show category-wise allocation of shares. Out of the total 20886200 shares, approximately 20% are reserved for QIB, 15% for NII, 35% for retail investors, and 30% for anchor investors.

Investor Category Shares Offered Maximum Allottees
Anchor Investor Shares Offered 6265860 (30%)
QIB Shares Offered 4177240 (20%)
NII (HNI) Shares Offered 3132930 (15%)
bHNI > ₹10L 2088620 (10%) 789
sHNI < ₹10L 1044310 (5%) 395
Retail Shares Offered 7310170 (35%) 38,678
Total Shares Offered 20886200 (100%)

Gaudium IVF & Women Health IPO Analytics

Gaudium IVF & Women Health IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.

Gaudium IVF & Women Health IPO Subscription Status

Gaudium IVF & Women Health IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.

The IPO is currently subscribed 7.27x, indicating strong demand across investor categories.

As on QIB
NII
bHNI
sHNI
Retail Total
Shares Offered / Reserved 41,77,240
31,32,930
20,88,620
10,44,310
73,10,170 1,46,20,340
Day 1 20-02-26 05:00 PM
0.00 x
0.91x
0.54x
1.64x
1.39 x 0.89 x
Day 2 23-02-26 05:00 PM
0.02 x
4.62x
3.52x
6.83x
4.02 x 3.01 x
Day 3 24-02-26 05:00 PM
1.62 x
14.05x
12.71x
16.73x
7.60 x 7.27 x
Total No. of Applications
bHNI sHNI Retail
249030 (Approx) 2.51x 15.94x 6.22x

Gaudium IVF & Women Health Valuations

Earnings

EPS Pre IPO
₹3.12/-
EPS Post IPO
₹3.44/-
P/E Pre IPO
25.36
P/E Post IPO
22.99

Returns

ROE
41.31%
ROCE
39.70%
RoNW
41.71%
PAT Margin
26.96%

Fundamentals

Debt / Equity
0.41
Price / Book
10.48
Market Cap
575.02 Cr.

Data sourced from DRHP / RHP • For educational purposes only

Gaudium IVF & Women Health Financials( In Crs.)

30-Sep-25 31-Mar-25 31-Mar-24 31-Mar-23
Assets 106.62 88.51 51.01 36.63
Revenue 49.75 70.96 48.15 44.26
Profit After Tax 12.51 19.13 10.32 13.53
Net Worth 58.85 46.30 26.99 22.73
Reserves & Surplus 28.16 15.60 26.00 21.74
Total Borrowing 22.51 18.93 15.73 9.78

Gaudium IVF & Women Health Company & Offer Insights

About Gaudium IVF & Women Health

Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization treatments throughout India and have expanded into several states utilizing a hub-and-spoke model.

The company has more than thirty locations. These include seven hubs (centres) and twenty-eight spokes. The strategic alliance between the organization and Infertility Experts, referred to as Spokes, was forged in order to meet the mutual goal of spreading awareness about Assisted Reproductive Technology or ART and In Vitro Fertilization or IVF treatments.The patients come from various countries such as Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.
The company has hubs in Delhi, two Janakpuri and Kailash Colony; Mumbai; Khar West; Ludhiana; Srinagar; Patna; and Bangalore, covering all important locations across the subcontinent.
This company offers a range of specialized fertility services: In Vitro Fertilization, Intracytoplasmic Sperm Injection, Intrauterine Insemination, and ovulation induction. Our treatments are specifically directed for a variety of infertility conditions in both males and females. We also provide comprehensive gynaecological care for PCOD/PCOS and endometriosis and high-risk pregnancy management for women with complex fertility history or health conditions.
These facilities cover a wide scope of male infertility treatments, right from advanced sperm retrieval techniques.

Gaudium IVF & Women Health Promoter(s)

Dr. Manika Khanna, Dr. Peeyush Khanna, Vishad Khanna are the company's promoters of Gaudium IVF & Women Health.

Gaudium IVF & Women Health IPO Issue Objectives

Funding capital expenditure towards establishment of New IVF Centers of the Company - ₹50 Cr.
Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company - ₹20 Cr.
General Corporate Purpose

Gaudium IVF & Women Health IPO - Anchor Investors

Gaudium IVF mobilises Rs 49.5 crore through anchor book for Rs 165-crore IPO.
Gaudium IVF has allocated 62.65 lakh shares to four anchor investors at the higher price band. Meru Investment Fund was the largest among the anchor investors, investing close to Rs 17 crore for 21.51 lakh shares, followed by Sanshi Fund, which invested 15.8 lakh shares worth Rs 12.5 crore.
Hornbill Orchid India Fund, and Carnelian India Multi-Strategy Fund invested 12.6 lakh shares worth Rs 10 crore each.

Gaudium IVF & Women Health IPO - Peers Comparison

P/B Ratio P/E Ratio RoNW Revenue(in Cr.)
Gaudium IVF N/A N/A 41.71% 70
Progyny Inc. 5.22 41.56 12.90% 10128
Inspire IVF 0.25 11.43 3.97% 26

Gaudium IVF & Women Health IPO - Strengths and Risks

Gaudium IVF & Women Health IPO strengths and risks highlight key business factors, financial position, and market sentiment that may impact investor interest.

Strengths

Patient Centric Pricing Approach: The Company offers package-based treatments, bundled services, and installment facilities to make fertility treatments more affordable for the middle-income group. This increases patient trust as well as the customer base.
Strong Brand Positioning & Trust Creation: The Company undertakes intensive patient education, brand credibility, and stigma reduction through patient education. It also obtains accreditations from recognized medical associations to enhance brand credibility and trust.
Focus on Medical Tourism: The Company takes advantage of the cost advantage of doing business in India. It attracts international patients through multiple language support, concierge services, and tie-ups with international agencies. It has tie-ups with international agencies to ensure a steady flow of international patients.

Risks

Operational & Medical Risks in Fertility Services: The Company provides fertility services like IVF, IUI, ICSI, and egg freezing, which expose the company to medical and operational risks. If the company fails to meet medical and healthcare standards, it may affect its reputation and financial performance.
Related Party Transactions & Potential Conflicts: The Company may have entered into and may continue to enter into related party transactions, which may include loans, advances, and guarantees to related parties.
Dependence on Limited Embryologists: The company operates across seven locations and relies on the services of five embryologists. The inability to retain and recruit qualified embryologists may affect the company's operations and financial condition.

Contact Information

Contact Details

Gaudium IVF & Women Health

011-4885 8585

compliance@gaudiumivfcentre.com

https://www.gaudiumivfcentre.com/

B1/51, Janak Puri, B-1, New Delhi, New Delhi, 110058

Registrar Contact Details

Bigshare Services Pvt Ltd

+91-22-6263 8200

ipo@bigshareonline.com

https://ipo.bigshareonline.com/ipo_status.html

Frequently Asked Questions

Click any question to reveal the answer

Gaudium IVF & Women Health IPO is a book-built IPO worth ₹165 crore. The price band is ₹75–₹79 per share. The IPO opens on Feb 20, 2026 and closes on Feb 24, 2026. It will be listed on BSE and NSE. Bigshare Services Pvt. Ltd. is the registrar.

The price band of Gaudium IVF & Women Health IPO is ₹75 to ₹79 per share.

The lot size of Gaudium IVF & Women Health IPO is 189 shares.

The minimum investment for Gaudium IVF & Women Health IPO is approximately ₹14,931 based on the upper price band .

Gaudium IVF & Women Health IPO opens on Feb 20, 2026 and closes on Feb 24, 2026.

The allotment date of Gaudium IVF & Women Health IPO is Feb 25, 2026.

Gaudium IVF & Women Health IPO is expected to be listed on Feb 27, 2026, on BSE and NSE .

Gaudium IVF & Women Health IPO listed on Feb 27, 2026. It was issued at ₹83.0(NSE) and is currently around ₹116.79 as on 27-May-2026 3:15 PM, which is approximately 47.8% versus issue price. The 52-week high is ₹133.00.

Based on listing and post-listing performance, Gaudium IVF & Women Health IPO delivered around 47.8% over issue price. Whether it was worth applying depends on your risk profile, allocation, and holding horizon.

To buy Gaudium IVF & Women Health IPO shares after listing, log in to your broker app (such as Zerodha, Angel One, Groww, Upstox, ICICI Direct), search the stock symbol, place a delivery/CNC order, and confirm quantity and price.

Gaudium IVF & Women Health IPO valuation snapshot: P/E 22.99, EPS ₹3.44/-, P/B 10.48, RoNW 41.71%, and market cap 575.02 Cr.

To apply for Gaudium IVF & Women Health IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.

You can check the live subscription status of Gaudium IVF & Women Health IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.

Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.

If you pre-apply for Gaudium IVF & Women Health IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.

You can check Gaudium IVF & Women Health IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Gaudium IVF & Women Health IPO allotment status on IPO Ji for quick and easy access.